Akari Therapeutics Plc CEO Rachelle Jacques' 2023 pay falls 57% to $1.6M
Akari Therapeutics Plc reports 2023 executive compensation
By ExecPay News
Published: June 3, 2024
Akari Therapeutics Plc reported fiscal year 2023 executive compensation information on June 3, 2024.
In 2023, three executives at Akari Therapeutics Plc received on average a compensation package of $668K, a 67% decrease compared to previous year.
Average pay of disclosed executives at Akari Therapeutics Plc
Rachelle Jacques, Chief Executive Officer, received $1.6M in total, which decreased by 57% compared to 2022. 47% of Jacques' compensation, or $729K, was in stock awards. Jacques also received $198K in option awards, $616K in salary, as well as $17K in other compensation.
Wendy DiCicco, Chief Financial Officer, received a compensation package of $278K. 81% of the compensation package, or $226K, was in salary.
Torsten Hombeck, Chief Financial Officer, earned $168K in 2023, a 63% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on June 3, 2024.